Close Menu

NEW YORK (GenomeWeb) – Bio-Techne said today that its fiscal 2019 second quarter revenues rose 13 percent year over year.

For the three months ended Dec. 31, 2018, the firm said revenues rose to $174.5 million from $154.2 million, beating the analysts' average estimate of $170.2 million.

In Q2, the firm's Diagnostics and Genomics revenues were $39.3 million, up 6 percent year over year from $37.1 million. Bio-Techne's Protein Sciences revenues were $135.5 million, up 16 percent from $117.1 million in the prior-year quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.